Form 4: DEXCOM INC: Insider Transaction Report

Jacob Steven Leach, President, CEO, and Director of DEXCOM INC, reported a transaction involving common stock on May 22, 2026.

Summary

• Jacob Steven Leach, who holds the positions of President, CEO, and Director at DEXCOM INC, has filed a Form 4 statement detailing a transaction.
• The transaction occurred on May 22, 2026.
• The filing indicates the withholding of 1,451 shares of common stock to cover tax obligations related to the net settlement of restricted stock units.
• Following this transaction, Mr. Leach beneficially owns 420,359 shares of common stock directly.
• Additionally, 47,296 shares are held indirectly through family holdings, specifically the Gregg Family Grandchildren's Trust.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it primarily details a routine tax withholding event related to executive compensation rather than a significant change in beneficial ownership or a strategic company move.

Positives

• The transaction primarily involved shares withheld for tax purposes, indicating a standard procedure for restricted stock unit settlements rather than an outright sale.
• Mr. Leach continues to hold a significant number of shares directly (420,359) and indirectly (47,296), suggesting continued commitment to the company.

Negatives

• The filing details the withholding of shares for tax purposes, which reduces the immediate number of shares available to the reporting person.

Risks

• The nature of restricted stock unit settlements and associated tax withholdings could be a point of concern for investors if not clearly understood.
• Indirect beneficial ownership through a trust introduces a layer of complexity in understanding ultimate control and beneficial interest.

Future Outlook

The filing does not contain forward-looking statements or guidance. It is a report of a past transaction.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions in publicly traded companies, providing transparency into the holdings and activities of key executives and directors. This filing for DEXCOM INC is typical for a company with a robust executive compensation structure involving equity awards.

Stakeholder Impact

• Shareholders: The filing provides transparency into executive holdings, which is a standard aspect of corporate governance. The tax withholding event is a routine part of equity compensation and is not expected to have a significant direct impact on share price.
• Employees: The transaction relates to the settlement of restricted stock units, which is part of the employee (executive) compensation plan.
• Management: The filing details a transaction by a key executive, Jacob Steven Leach, President, CEO, and Director.

Key Dates

Keywords

Form 4, Insider Transaction, DEXCOM INC, DXCM, Jacob Steven Leach, Common Stock, Restricted Stock Units, Beneficial Ownership, SEC Filing